MedDRA version: 14.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
Conditions
Interventions
Product Name: Afatinib
Product Code: BIBW2992
Pharmaceutical Form: Tablet
CAS Number: 439081-18-2
Current Sponsor code: BIBW2992
Other descriptive name: Afatinib
Concentration unit: mg milligram(s)
Co
Sponsors
FNCLCC
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: ;Secondary Objective: ;Primary end point(s): | — |
Countries
France
Outcome results
None listed